Tan AC - Search Results

1

The landscape of tyrosine kinase inhibitors in sarcomas: looking beyond pazopanib.

Wilding CP, Elms ML, Judson I, Tan AC, Jones RL, Huang PH. Wilding CP, et al. Among authors: tan ac. Expert Rev Anticancer Ther. 2019 Nov;19(11):971-991. doi: 10.1080/14737140.2019.1686979. Epub 2019 Nov 13. Expert Rev Anticancer Ther. 2019. PMID: 31665941 Free PMC article. Review.

2

Expanding the computational toolbox for interrogating cancer kinomes.

Tan AC, Ryall KA, Huang PH. Tan AC, et al. Pharmacogenomics. 2016;17(2):95-7. doi: 10.2217/pgs.15.154. Epub 2015 Dec 15. Pharmacogenomics. 2016. PMID: 26666839 Free article. No abstract available.

3

Exploiting receptor tyrosine kinase co-activation for cancer therapy.

Tan AC, Vyse S, Huang PH. Tan AC, et al. Drug Discov Today. 2017 Jan;22(1):72-84. doi: 10.1016/j.drudis.2016.07.010. Epub 2016 Jul 21. Drug Discov Today. 2017. PMID: 27452454 Free PMC article. Review.

4

Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer.

Todd JR, Ryall KA, Vyse S, Wong JP, Natrajan RC, Yuan Y, Tan AC, Huang PH. Todd JR, et al. Among authors: tan ac. Oncotarget. 2016 Sep 27;7(39):62939-62953. doi: 10.18632/oncotarget.11307. Oncotarget. 2016. PMID: 27556857 Free PMC article.

5

Dual Targeting of PDGFRα and FGFR1 Displays Synergistic Efficacy in Malignant Rhabdoid Tumors.

Wong JP, Todd JR, Finetti MA, McCarthy F, Broncel M, Vyse S, Luczynski MT, Crosier S, Ryall KA, Holmes K, Payne LS, Daley F, Wai P, Jenks A, Tanos B, Tan AC, Natrajan RC, Williamson D, Huang PH. Wong JP, et al. Among authors: tan ac. Cell Rep. 2016 Oct 25;17(5):1265-1275. doi: 10.1016/j.celrep.2016.10.005. Cell Rep. 2016. PMID: 27783942 Free PMC article.

6

Translational genomics for rare cancers: Challenges and opportunity.

Tan AC, Huang PH. Tan AC, et al. Semin Cancer Biol. 2020 Apr;61:iii-iv. doi: 10.1016/j.semcancer.2020.02.014. Epub 2020 Feb 21. Semin Cancer Biol. 2020. PMID: 32092353 No abstract available.

7

p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer.

Tentler JJ, Ionkina AA, Tan AC, Newton TP, Pitts TM, Glogowska MJ, Kabos P, Sartorius CA, Sullivan KD, Espinosa JM, Eckhardt SG, Diamond JR. Tentler JJ, et al. Among authors: tan ac. Mol Cancer Ther. 2015 May;14(5):1117-29. doi: 10.1158/1535-7163.MCT-14-0538-T. Epub 2015 Mar 10. Mol Cancer Ther. 2015. PMID: 25758253 Free PMC article.

8

Coupling an EML4-ALK-centric interactome with RNA interference identifies sensitizers to ALK inhibitors.

Zhang G, Scarborough H, Kim J, Rozhok AI, Chen YA, Zhang X, Song L, Bai Y, Fang B, Liu RZ, Koomen J, Tan AC, Degregori J, Haura EB. Zhang G, et al. Among authors: tan ac. Sci Signal. 2016 Oct 18;9(450):rs12. doi: 10.1126/scisignal.aaf5011. Sci Signal. 2016. PMID: 27811184 Free PMC article.

9

The mutational landscape of mucosal melanoma.

Nassar KW, Tan AC. Nassar KW, et al. Among authors: tan ac. Semin Cancer Biol. 2020 Apr;61:139-148. doi: 10.1016/j.semcancer.2019.09.013. Epub 2019 Oct 23. Semin Cancer Biol. 2020. PMID: 31655118 Free PMC article. Review.

10

Preclinical and Dose-Finding Phase I Trial Results of Combined Treatment with a TORC1/2 Inhibitor (TAK-228) and Aurora A Kinase Inhibitor (Alisertib) in Solid Tumors.

Davis SL, Ionkina AA, Bagby SM, Orth JD, Gittleman B, Marcus JM, Lam ET, Corr BR, O'Bryant CL, Glode AE, Tan AC, Kim J, Tentler JJ, Capasso A, Lopez KL, Gustafson DL, Messersmith WA, Leong S, Eckhardt SG, Pitts TM, Diamond JR. Davis SL, et al. Among authors: tan ac. Clin Cancer Res. 2020 Sep 1;26(17):4633-4642. doi: 10.1158/1078-0432.CCR-19-3498. Epub 2020 May 15. Clin Cancer Res. 2020. PMID: 32414750 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

585 results

Search Page